Skip to main content
Equibles

PRINCIPAL FINANCIAL GROUP INC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1126328 DES MOINES, IA
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$44,181,166
+$9,094,149 QoQ
Shares Held
541,635
+5.2% QoQ
Ownership
0.649%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#45
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. PTCT ranks #11 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 873,502 $232,980,453
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 389,511 $193,481,798
3 CYTK
Cytokinetics Inc
 1,311,664 $111,740,655
4 GPCR
Structure Therapeutics Inc.
 1,752,753 $94,070,253
5 INSM
INSMED Inc
 856,126 $91,280,154
6 AXSM
Axsome Therapeutics, Inc.
 332,642 $81,420,782
7 BBIO
BridgeBio Pharma, Inc.
 1,024,423 $76,299,024
8 REGN
Regeneron Pharmaceuticals, Inc.
 121,053 $75,481,386

All Filings in PTCT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,181,166 541,635
2026-03-31 $35,087,017 515,001
2025-12-31 $36,377,015 478,897
2025-09-30 $4,153,336 67,677
2025-06-30 $2,637,359 54,000
2025-03-31 $297,606 5,840
2024-12-31 $268,808 5,955
2024-09-30 $247,679 6,676
2024-06-30 $376,805 12,322
2024-03-31 $516,754 17,764
2023-12-31 $481,583 17,474
2023-09-30 $394,953 17,624
2023-06-30 $703,631 17,301
2023-03-31 $864,992 17,857
2022-12-31 $689,693 18,069
2022-09-30 $887,133 17,672
2022-06-30 $686,748 17,143
2022-03-31 $776,718 20,818
2021-12-31 $807,552 20,275
2021-09-30 $1,076,670 28,935
2021-06-30 $1,155,619 27,339
2021-03-31 $1,336,642 28,229
2020-12-31 $1,808,501 29,633
2020-09-30 $1,047,526 22,407
2020-06-30 $1,195,028 23,552
2020-03-31 $747,305 16,752